HF
MRM

HRT Financial’s MEDIROM Healthcare Technologies MRM Stock Holding History

HRT Financial’s Portfolio MRM Stock Details MRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$56K Buy
54,755
+42,850
+360% +$48.2K ﹤0.01% 3743
2026
Q1 		$13K Buy
+11,905
New +$17.3K ﹤0.01% 3612

Other funds holding MRM

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return

HRT Financial's MRM Position: Q2 2026 in Review

HRT Financial increased its MEDIROM Healthcare Technologies (MRM) stake by 360% in Q2 2026, buying an estimated $48.2K and bringing the position to 54,755 shares worth $56K. The position accounts for ﹤0.01% of the portfolio, ranked #3743.

HRT Financial first reported a position in MRM in Q1 2026 and has held it in 2 quarters since. 8 funds tracked by Wall St. Rank hold MRM as of Q2 2026.

  • HRT Financial held 54,755 shares of MEDIROM Healthcare Technologies worth $56K as of Q2 2026.
  • HRT Financial bought 42,850 MEDIROM Healthcare Technologies shares in Q2 2026, an estimated $48.2K.
  • MEDIROM Healthcare Technologies made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3743 holding.
  • HRT Financial first reported a position in MEDIROM Healthcare Technologies in Q1 2026 and has held it in 2 quarters since.
  • 8 funds tracked by Wall St. Rank held MEDIROM Healthcare Technologies as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.